The trademark application TELUM THERAPEUTICS was filed by TELUM THERAPEUTICS S.L., a corporation established under the laws of the Kingdom of Spain (the "Applicant"). The application was published for oppositions on October 12, 2021, and it was registered by office on January 19, 2022 without any oppositions.
It was designated 'Basic Application' for International Application 1627526 at the World Intellectual Property Organization (WIPO).
The application was filed in Spanish (English was selected as the second language).
Goods And Services
The mark was filed in class 1 with following description of goods:
Diagnostic preparations for scientific purposes
Reagents for medical research
Reagents for medical research in the field of infectious diseases and diseases caused by bacteria
Diagnostic reagents for scientific or research use
Enzymes for scientific purposes
Diagnostic kits comprising specimen receptors and reagents for testing for selected bacteria.
The mark was filed in class 5 with following description of goods:
Pharmaceutical products for the treatment of infectious diseases
Pharmaceutical products for the treatment of diseases caused by bacteria
Antibacterial pharmaceuticals
Antibiotics
Biopharmaceuticals for the treatment of infectious diseases
Immunotherapeutic agents for bacterial infections
Enzyme preparations for medical purposes
Enzymes for medical purposes
Enzymes and enzyme preparations for the diagnosis, prognosis and treatment of infectious diseases and diseases caused by bacteria
Assays, biomarkers and reagents for the diagnosis, prognosis and treatment of infectious diseases and diseases caused by bacteria.
The mark was filed in class 42 with following description of goods:
Biomedical research services
Scientific research for medical purposes in the field of infectious diseases and diseases caused by bacteria
Research and development of pharmaceutical products, antibiotics, assays, biomarkers and reagents for the diagnosis, prognosis and treatment of infectious diseases and diseases caused by bacteria
Research and development of immunotherapeutic agents for bacterial infections
Research and development of enzymes, enzyme preparations and synthetic proteins for the diagnosis, prognosis and treatment of infectious diseases and diseases caused by bacteria
Clinical trials of pharmaceutical products, antibiotics, assays, biomarkers and reagents for the diagnosis, prognosis and treatment of infectious diseases and diseases caused by bacteria.